BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32711842)

  • 21. A modern approach for epitope prediction: identification of foot-and-mouth disease virus peptides binding bovine leukocyte antigen (BoLA) class I molecules.
    Pandya M; Rasmussen M; Hansen A; Nielsen M; Buus S; Golde W; Barlow J
    Immunogenetics; 2015 Nov; 67(11-12):691-703. PubMed ID: 26496773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity data.
    Garde C; Ramarathinam SH; Jappe EC; Nielsen M; Kringelum JV; Trolle T; Purcell AW
    Immunogenetics; 2019 Jul; 71(7):445-454. PubMed ID: 31183519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data.
    Jurtz V; Paul S; Andreatta M; Marcatili P; Peters B; Nielsen M
    J Immunol; 2017 Nov; 199(9):3360-3368. PubMed ID: 28978689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [MHC-I epitope presentation prediction based on transfer learning].
    Hu WP; Li YP; Zhang XQ
    Yi Chuan; 2019 Nov; 41(11):1041-1049. PubMed ID: 31735706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep convolutional neural networks for pan-specific peptide-MHC class I binding prediction.
    Han Y; Kim D
    BMC Bioinformatics; 2017 Dec; 18(1):585. PubMed ID: 29281985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity.
    Rasmussen M; Fenoy E; Harndahl M; Kristensen AB; Nielsen IK; Nielsen M; Buus S
    J Immunol; 2016 Aug; 197(4):1517-24. PubMed ID: 27402703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MHCSeqNet: a deep neural network model for universal MHC binding prediction.
    Phloyphisut P; Pornputtapong N; Sriswasdi S; Chuangsuwanich E
    BMC Bioinformatics; 2019 May; 20(1):270. PubMed ID: 31138107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Class I and class II MHC bind self peptide sets that are strikingly different in their evolutionary characteristics.
    Yeager M; Carrington M; Hughes AL
    Immunogenetics; 2000 Jan; 51(1):8-15. PubMed ID: 10663556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and Structure of an MHC Class I-Encoded Protein with the Potential to Present
    Yamamoto Y; Morita D; Shima Y; Midorikawa A; Mizutani T; Suzuki J; Mori N; Shiina T; Inoko H; Tanaka Y; Mikami B; Sugita M
    J Immunol; 2019 Jun; 202(12):3349-3358. PubMed ID: 31043477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of MHC class I binding peptides using profile motifs.
    Reche PA; Glutting JP; Reinherz EL
    Hum Immunol; 2002 Sep; 63(9):701-9. PubMed ID: 12175724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome.
    Boehm KM; Bhinder B; Raja VJ; Dephoure N; Elemento O
    BMC Bioinformatics; 2019 Jan; 20(1):7. PubMed ID: 30611210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing.
    Neisig A; Wubbolts R; Zang X; Melief C; Neefjes J
    J Immunol; 1996 May; 156(9):3196-206. PubMed ID: 8617941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules.
    Appella E; Padlan EA; Hunt DF
    EXS; 1995; 73():105-19. PubMed ID: 7579970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen Processing.
    O'Donnell TJ; Rubinsteyn A; Laserson U
    Cell Syst; 2020 Oct; 11(4):418-419. PubMed ID: 33091335
    [No Abstract]   [Full Text] [Related]  

  • 37. Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.
    Remesh SG; Andreatta M; Ying G; Kaever T; Nielsen M; McMurtrey C; Hildebrand W; Peters B; Zajonc DM
    J Biol Chem; 2017 Mar; 292(13):5262-5270. PubMed ID: 28179428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NetMHCcons: a consensus method for the major histocompatibility complex class I predictions.
    Karosiene E; Lundegaard C; Lund O; Nielsen M
    Immunogenetics; 2012 Mar; 64(3):177-86. PubMed ID: 22009319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and Identification of Naturally Presented MHC Class I and II Ligands.
    Nelde A; Kowalewski DJ; Stevanović S
    Methods Mol Biol; 2019; 1988():123-136. PubMed ID: 31147937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ProPred1: prediction of promiscuous MHC Class-I binding sites.
    Singh H; Raghava GP
    Bioinformatics; 2003 May; 19(8):1009-14. PubMed ID: 12761064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.